查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1532276

妊娠纹治疗市场：2024-2033年全球产业分析、规模、占有率、成长、趋势、预测

Stretch Marks Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球妊娠纹治疗市场的综合报告。本报告全面评估了主要市场动态，包括市场驱动因素、趋势、机会和挑战，并提供了有关市场结构的详细见解。

关键见解

  • 妊娠纹治疗市场规模（2024年）：29亿美元
  • 预测市值（2033年）：46亿美元
  • 全球市场成长率（2024年至2033年年复合成长率）：5.3%

妊娠纹治疗市场 - 报告范围：

妊娠纹是一种常见的皮肤病，是由于皮肤快速拉伸引起的，又称为皮纹或皮纹。妊娠纹治疗市场包括各种治疗选择，例如局部治疗、雷射治疗和手术介入。这些治疗目的是减少妊娠纹的出现并改善皮肤纹理。该市场服务于广泛的客户，包括寻求美容改善的个人、提供专业治疗的医疗保健提供者以及提供先进解决方案的美容诊所。市场成长的驱动力是人们对皮肤美容意识的提高、生活方式和荷尔蒙变化导致的妊娠纹患病率上升以及治疗技术的进步。

市场驱动因素：

全球妊娠纹治疗市场由几个关键因素推动，例如人们对有效治疗方案可用性的认识不断提高。由于怀孕、体重快速增加和青春期等因素，妊娠纹的发生率不断增加，导致治疗需求增加。技术进步，例如非侵入性雷射治疗和增强的局部製剂的开发，提高疗效和患者舒适度。此外，美学的提高和对整容手术的日益重视推动市场扩张。可支配收入的增加和个人化护肤趋势的成长进一步促进了市场的成长。

市场限制因素：

儘管成长前景广阔，妊娠纹治疗市场仍面临成本和可及性方面的挑战。雷射治疗和外科手术等先进治疗方法价格昂贵，某些人可能无法接受。此外，治疗效果可能会因个人皮肤类型和妊娠纹严重程度而异，这可能会影响患者满意度和治疗结果。市场也面临监管合规性以及需要持续研究以验证治疗有效性和安全性的挑战。

市场机会：

由于技术创新、人口趋势和不断变化的消费者偏好，妊娠纹治疗市场提供了巨大的成长机会。射频和超音波治疗等新技术的整合增强治疗选择。对个人化皮肤护理解决方案的日益关注和微创手术的日益普及为市场参与者开闢了新的途径。策略合作伙伴关係、研发投资以及引进负担得起且有效的治疗方法对于利用新机会和维持市场领先地位非常重要。

本报告涵盖的主要问题

  • 推动全球妊娠纹治疗市场成长的关键因素是什么？
  • 哪些类型的治疗和应用推动不同患者群体的采用？
  • 技术进步如何改变妊娠纹治疗市场的竞争格局？
  • 谁是妊娠纹治疗市场的主要参与者？
  • 全球妊娠纹治疗市场的新趋势和未来前景是什么？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含和排除

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 治疗类型创新/发展趋势

第4章 关键成功因素

  • 波特的分析
  • PESTEL 分析
  • 皮肤科/美容外科医生，主要国家
  • 主要国家的皮肤科/美容外科诊所
  • 依地区划分的美容护理数量
  • 依地区划分的怀孕人数
  • 付款人组合分析
  • 主要参与者的促销策略
  • 医疗保健偿付和资金结构
  • 监管场景
  • 母市场分析

第5章 市场背景

  • 宏观经济因素
  • 预测因子 - 相关性和影响
  • 动态

第6章 COVID-19 危机 - 影响评估

  • 新冠肺炎（COVID-19）与影响分析
    • 依治疗类型
    • 依妊娠纹类型
    • 依最终用户
    • 依地区
  • 2023年市场情景

第7章 全球市场需求（金额或规模）分析

  • 2019-2023年市场价值分析
  • 2024-2033年市场价值预测
    • 年成长趋势分析
    • 绝对的获利机会

第8章 依治疗类型：世界市场分析

  • 简介/主要发现
  • 2019-2023年市场规模（金额与数量）分析
  • 2024-2033年市场规模（金额和数量）分析与预测
    • 外用药
      • 凝胶
      • 乳膏
      • 油/精华液
    • 手术治疗
      • 高频疗法
      • 非 非汽化剥离式雷射点阵换肤
      • 烧蚀雷射换肤
      • 红外线装置/辐射
      • 皮肤剥离
      • 化学剥离
  • 依治疗类型的市场吸引力分析

第9章 妊娠纹类型：世界市场分析

  • 简介/主要发现
  • 2019-2023年市场规模（金额）分析
  • 2024-2033年市场规模（金额）分析与预测
    • 萎缩性皮纹（皮肤薄化）
    • 妊娠纹（怀孕后）
    • 妊娠扩张纹
    • 红色条纹
    • 白色条纹
    • 黑色条纹
    • 蓝色条纹
  • 依妊娠纹类型：市场吸引力分析

第10章 依最终使用者：世界市场分析

  • 简介/主要发现
  • 2019-2023年市场规模（金额）分析
  • 2024-2033年市场规模（金额）分析与预测
    • 医院
    • 皮肤科诊所
    • 美容诊所
    • 健康与水疗中心
    • 居家照护环境
  • 依最终用户的市场吸引力分析

第11章 依区域：世界市场分析

  • 简介
  • 2019-2023年市场规模（金额）分析
  • 2024-2033年市场规模（金额）分析与预测
    • 北美
    • 拉丁美洲
    • 欧洲
    • 南亚
    • 东亚
    • 大洋洲
    • 中东和非洲（中东、非洲）
  • 依区域市场吸引力分析

第12章 北美市场分析

第13章 拉丁美洲市场分析

第14章 欧洲市场分析

第15章 南亚市场分析

第16章 东亚市场分析

第17章 大洋洲市场分析

第18章 中东、非洲市场分析

第19章 市场结构分析

  • 依公司层级的市场分析
  • 主要公司市占率分析
  • 市场现况分析

第20章 竞争分析

  • 竞争仪表板
  • 竞争基准
  • 竞争详情
    • Weleda
    • Clarins
    • basq NYC
    • Body Merry
    • Himalaya Global Holdings Ltd.
    • Stratpharma AG（Stratpharma Inc.）
    • Browne Drug Co., Inc.（Palmer's）
    • Mederma（HRA Pharma）
    • Givaudan SA
    • NEOSTRATA COMPANY, INC.（Johnson &Johnson Services, Inc.）
    • Bio-Oil（Union Swiss（Pty）Ltd）
    • Merz Pharma
    • Dermaclara
    • Unilever

第21章 使用的先决条件与缩写

第22章 研究方法

简介目录
Product Code: PMRREP33375

Persistence Market Research has recently released a comprehensive report on the global stretch marks treatment market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Stretch Marks Treatment Market Size (2024E): USD 2.9 Billion
  • Projected Market Value (2033F): USD 4.6 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.3%

Stretch Marks Treatment Market - Report Scope:

Stretch marks, also known as striae or striae distensae, are a common skin condition that occurs due to rapid stretching of the skin. The stretch marks treatment market encompasses various therapeutic options, including topical treatments, laser therapies, and surgical interventions. These treatments aim to reduce the appearance of stretch marks and improve skin texture. The market serves a wide range of customers, including individuals seeking cosmetic improvements, healthcare providers offering specialized treatments, and aesthetic clinics providing advanced solutions. Market growth is driven by increasing awareness of skin aesthetics, rising prevalence of stretch marks due to lifestyle and hormonal changes, and advancements in treatment technologies.

Market Growth Drivers:

The global stretch marks treatment market is propelled by several key factors, including growing awareness about the availability of effective treatment options. Increasing instances of stretch marks due to factors such as pregnancy, rapid weight gain, and puberty contribute to the rising demand for treatments. Technological advancements, such as the development of non-invasive laser treatments and enhanced topical formulations, offer improved efficacy and patient comfort. Additionally, the increasing emphasis on aesthetic enhancements and cosmetic procedures is driving market expansion. The rise in disposable incomes and the growing trend of personalized skincare further contribute to market growth.

Market Restraints:

Despite promising growth prospects, the stretch marks treatment market faces challenges related to cost and accessibility. The high cost of advanced treatments, such as laser therapies and surgical interventions, can limit accessibility for some individuals. Additionally, the effectiveness of treatments can vary depending on individual skin types and the severity of the stretch marks, which may affect patient satisfaction and treatment outcomes. The market also encounters challenges related to regulatory compliance and the need for continued research to validate treatment efficacy and safety.

Market Opportunities:

The stretch marks treatment market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving consumer preferences. The integration of new technologies, such as radiofrequency and ultrasound-based treatments, offers enhanced treatment options. The increasing focus on personalized skincare solutions and the growing popularity of minimally invasive procedures create new avenues for market players. Strategic partnerships, investment in research and development, and the introduction of affordable and effective treatments are essential to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the stretch marks treatment market globally?
  • Which treatment types and applications are driving adoption across different patient demographics?
  • How are technological advancements reshaping the competitive landscape of the stretch marks treatment market?
  • Who are the key players contributing to the stretch marks treatment market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global stretch marks treatment market?

Competitive Intelligence and Business Strategy:

Leading players in the global stretch marks treatment market, including Allergan PLC, Revance Therapeutics, Inc., and Syneron Candela, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced treatment solutions, including novel topical agents, laser devices, and minimally invasive procedures. Collaborations with dermatologists, aesthetic clinics, and research institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the dynamic stretch marks treatment landscape.

Key Companies Profiled:

  • Weleda
  • Clarins
  • basq NYC
  • Body Merry
  • Himalaya Global Holdings Ltd.
  • Stratpharma AG (Stratpharma Inc.)
  • Browne Drug Co., Inc. (Palmer's)
  • Mederma (HRA Pharma)
  • Givaudan SA
  • NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
  • Bio-Oil (Union Swiss (Pty) Ltd)
  • Merz Pharma
  • Dermaclara
  • Unilever

Key Segments of Stretch Marks Treatment Industry Research

By Treatment:

  • Topical Medications
  • Procedural Treatments

By Stretch Mark Type:

  • Striae atrophicans (Thinned Skin)
  • Striae gravidarum (Post Pregnancy)
  • Striae distensae (Stretched Skin)
  • striae rubrae (Red)
  • Striae albae (White)
  • Striae nigra (Black)
  • Striae caerulea (Dark Blue)

By End User:

  • Hospitals
  • Dermatology Clinics
  • Aesthetic Clinics
  • Wellness and Spa Centers
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • Europe Stretch
  • South Asia Stretch
  • East Asia Stretch
  • Oceania Stretch
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Treatment Type Innovation / Development Trends

4. Key Success Factors

  • 4.1. Porter's Analysis
  • 4.2. PESTEL Analysis
  • 4.3. Dermatologists/Cosmetic Surgeons, Key Country
  • 4.4. Dermatology/Cosmetic Surgery Clinics, Key Country
  • 4.5. Number of Aesthetic Procedures, By Region
  • 4.6. Number of Pregnancy, By Region
  • 4.7. Payer Mix Analysis
  • 4.8. Promotional Strategies, By Key Players
  • 4.9. Healthcare Reimbursement and Financing Structure
  • 4.10. Regulatory Scenario
  • 4.11. Parent Market Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Life Expectancy Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Cases of Pregnancy
    • 5.2.2. Rising Disposable Per Capita Income
    • 5.2.3. Adoption of Aesthetic Treatments
    • 5.2.4. Changes in Lifestyle
    • 5.2.5. Shift from Invasive to Non-invasive Laser Therapies
    • 5.2.6. Presence of Highly Skilled Workforce
    • 5.2.7. Media Coverage and Awareness from Celebrities
    • 5.2.8. New/Improved Product Launches
    • 5.2.9. Growing Investment in Healthcare Expenditure
    • 5.2.10. Mergers and Acquisitions
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Treatment Type
    • 6.1.2. By Stretch Marks Type
    • 6.1.3. BY End User
    • 6.1.4. By Region
  • 6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Treatment Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Treatment Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Treatment Type, 2024-2033
    • 8.3.1. Topical Medications
      • 8.3.1.1. Gels
      • 8.3.1.2. Creams
      • 8.3.1.3. Oils/Serums
    • 8.3.2. Procedural Treatments
      • 8.3.2.1. Radiofrequency Therapy
      • 8.3.2.2. Nonablative Laser Fractional Resurfacing
      • 8.3.2.3. Ablative Laser Resurfacing
      • 8.3.2.4. Infrared Devices/Radiations
      • 8.3.2.5. Dermabrasion
      • 8.3.2.6. Chemical Peel
  • 8.4. Market Attractiveness Analysis By Treatment Type

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Stretch Marks Type

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Stretch Marks Type, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Stretch Marks Type, 2024-2033
    • 9.3.1. Striae Atrophicans (Thinned Skin)
    • 9.3.2. Striae Gravidarum (Post Pregnancy)
    • 9.3.3. Striae Distensae (Stretched Skin)
    • 9.3.4. Striae Rubrae (Red)
    • 9.3.5. Striae Albae (White)
    • 9.3.6. Striae Nigra (Black)
    • 9.3.7. Striae Caerulea (Dark Blue)
  • 9.4. Market Attractiveness Analysis By Stretch Marks Type

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Dermatology Clinics
    • 10.3.3. Aesthetic Clinics
    • 10.3.4. Wellness and Spa Centers
    • 10.3.5. Home Care Settings
  • 10.4. Market Attractiveness Analysis By End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. South Asia
    • 11.3.5. East Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Treatment Type
    • 12.3.3. By Stretch Marks Type
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Treatment Type
    • 12.4.3. By Stretch Marks Type
    • 12.4.4. By End User
  • 12.5. Country Level Analysis & Forecast
    • 12.5.1. U.S. Market Analysis
      • 12.5.1.1. .Introduction
      • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.1.2.1. By Treatment Type
        • 12.5.1.2.2. By Stretch Marks Type
        • 12.5.1.2.3. By End User
    • 12.5.2. Canada Market Analysis
      • 12.5.2.1. Introduction
      • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.2.2.1. By Treatment Type
        • 12.5.2.2.2. By Stretch Marks Type
        • 12.5.2.2.3. By End User
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Stretch Marks Type
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Treatment Type
    • 13.4.3. By Stretch Marks Type
    • 13.4.4. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. Brazil Market Analysis
      • 13.5.1.1. .Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Treatment Type
        • 13.5.1.2.2. By Stretch Marks Type
        • 13.5.1.2.3. By End User
    • 13.5.2. Mexico Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Treatment Type
        • 13.5.2.2.2. By Stretch Marks Type
        • 13.5.2.2.3. By End User
    • 13.5.3. Argentina Market Analysis
      • 13.5.3.1. Introduction
      • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.3.2.1. By Treatment Type
        • 13.5.3.2.2. By Stretch Marks Type
        • 13.5.3.2.3. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Bn) and Volume (Units) Forecast, By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. France
      • 14.3.1.3. Italy
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. Russia
      • 14.3.1.7. BENELUX
      • 14.3.1.8. Nordic Countries
      • 14.3.1.9. Rest of Europe
    • 14.3.2. By Treatment Type
    • 14.3.3. By Stretch Marks Type
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Treatment Type
    • 14.4.3. By Stretch Marks Type
    • 14.4.4. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. Germany Market Analysis
      • 14.5.1.1. .Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Treatment Type
        • 14.5.1.2.2. By Stretch Marks Type
        • 14.5.1.2.3. By End User
    • 14.5.2. France Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Treatment Type
        • 14.5.2.2.2. By Stretch Marks Type
        • 14.5.2.2.3. By End User
    • 14.5.3. Italy Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Treatment Type
        • 14.5.3.2.2. By Stretch Marks Type
        • 14.5.3.2.3. By End User
    • 14.5.4. U.K. Market Analysis
      • 14.5.4.1. .Introduction
      • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.4.2.1. By Treatment Type
        • 14.5.4.2.2. By Stretch Marks Type
        • 14.5.4.2.3. By End User
    • 14.5.5. Spain Market Analysis
      • 14.5.5.1. .Introduction
      • 14.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.5.2.1. By Treatment Type
        • 14.5.5.2.2. By Stretch Marks Type
        • 14.5.5.2.3. By End User
    • 14.5.6. Russia Market Analysis
      • 14.5.6.1. .Introduction
      • 14.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.6.2.1. By Treatment Type
        • 14.5.6.2.2. By Stretch Marks Type
        • 14.5.6.2.3. By End User
    • 14.5.7. Nordic Countries Market Analysis
      • 14.5.7.1. .Introduction
      • 14.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.7.2.1. By Treatment Type
        • 14.5.7.2.2. By Stretch Marks Type
        • 14.5.7.2.3. By End User
    • 14.5.8. BENELUX Market Analysis
      • 14.5.8.1. .Introduction
      • 14.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.8.2.1. By Treatment Type
        • 14.5.8.2.2. By Stretch Marks Type
        • 14.5.8.2.3. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Treatment Type
    • 15.3.3. By Stretch Marks Type
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Treatment Type
    • 15.4.3. By Stretch Marks Type
    • 15.4.4. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. India Market Analysis
      • 15.5.1.1. .Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Treatment Type
        • 15.5.1.2.2. By Stretch Marks Type
        • 15.5.1.2.3. By End User
    • 15.5.2. Thailand Market Analysis
      • 15.5.2.1. .Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Treatment Type
        • 15.5.2.2.2. By Stretch Marks Type
        • 15.5.2.2.3. By End User
    • 15.5.3. Indonesia Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Treatment Type
        • 15.5.3.2.2. By Stretch Marks Type
        • 15.5.3.2.3. By End User
    • 15.5.4. Malaysia Market Analysis
      • 15.5.4.1. Introduction
      • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.4.2.1. By Treatment Type
        • 15.5.4.2.2. By Stretch Marks Type
        • 15.5.4.2.3. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Treatment Type
    • 16.3.3. By Stretch Marks Type
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Treatment Type
    • 16.4.3. By Stretch Marks Type
    • 16.4.4. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. China Market Analysis
      • 16.5.1.1. .Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Treatment Type
        • 16.5.1.2.2. By Stretch Marks Type
        • 16.5.1.2.3. By End User
    • 16.5.2. Japan Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Treatment Type
        • 16.5.2.2.2. By Stretch Marks Type
        • 16.5.2.2.3. By End User
    • 16.5.3. South Korea Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Treatment Type
        • 16.5.3.2.2. By Stretch Marks Type
        • 16.5.3.2.3. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Treatment Type
    • 17.3.3. By Stretch Marks Type
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Treatment Type
    • 17.4.3. By Stretch Marks Type
    • 17.4.4. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. Australia Market Analysis
      • 17.5.1.1. .Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Treatment Type
        • 17.5.1.2.2. By Stretch Marks Type
        • 17.5.1.2.3. By End User
    • 17.5.2. New Zealand Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Treatment Type
        • 17.5.2.2.2. By Stretch Marks Type
        • 17.5.2.2.3. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. Northern Africa
      • 18.3.1.4. South Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Treatment Type
    • 18.3.3. By Stretch Marks Type
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Treatment Type
    • 18.4.3. By Stretch Marks Type
    • 18.4.4. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. GCC Countries Market Analysis
      • 18.5.1.1. .Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Treatment Type
        • 18.5.1.2.2. By Stretch Marks Type
        • 18.5.1.2.3. By End User
    • 18.5.2. Turkiye Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Treatment Type
        • 18.5.2.2.2. By Stretch Marks Type
        • 18.5.2.2.3. By End User
    • 18.5.3. Northern Africa Market Analysis
      • 18.5.3.1. Introduction
      • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.3.2.1. By Treatment Type
        • 18.5.3.2.2. By Stretch Marks Type
        • 18.5.3.2.3. By End User
    • 18.5.4. South Africa Market Analysis
      • 18.5.4.1. Introduction
      • 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.4.2.1. By Treatment Type
        • 18.5.4.2.2. By Stretch Marks Type
        • 18.5.4.2.3. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Weleda
      • 20.3.1.1. Overview
      • 20.3.1.2. Treatment Type Portfolio
      • 20.3.1.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.1.4. Sales Footprint
      • 20.3.1.5. Strategy Overview
    • 20.3.2. Clarins
      • 20.3.2.1. Overview
      • 20.3.2.2. Treatment Type Portfolio
      • 20.3.2.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.2.4. Sales Footprint
      • 20.3.2.5. Strategy Overview
    • 20.3.3. basq NYC
      • 20.3.3.1. Overview
      • 20.3.3.2. Treatment Type Portfolio
      • 20.3.3.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.3.4. Sales Footprint
      • 20.3.3.5. Strategy Overview
    • 20.3.4. Body Merry
      • 20.3.4.1. Overview
      • 20.3.4.2. Treatment Type Portfolio
      • 20.3.4.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.4.4. Sales Footprint
      • 20.3.4.5. Strategy Overview
    • 20.3.5. Himalaya Global Holdings Ltd.
      • 20.3.5.1. Overview
      • 20.3.5.2. Treatment Type Portfolio
      • 20.3.5.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.5.4. Sales Footprint
      • 20.3.5.5. Strategy Overview
    • 20.3.6. Stratpharma AG (Stratpharma Inc.)
      • 20.3.6.1. Overview
      • 20.3.6.2. Treatment Type Portfolio
      • 20.3.6.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.6.4. Sales Footprint
      • 20.3.6.5. Strategy Overview
    • 20.3.7. Browne Drug Co., Inc. (Palmer's)
      • 20.3.7.1. Overview
      • 20.3.7.2. Treatment Type Portfolio
      • 20.3.7.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.7.4. Sales Footprint
      • 20.3.7.5. Strategy Overview
    • 20.3.8. Mederma (HRA Pharma)
      • 20.3.8.1. Overview
      • 20.3.8.2. Treatment Type Portfolio
      • 20.3.8.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.8.4. Sales Footprint
      • 20.3.8.5. Strategy Overview
    • 20.3.9. Givaudan SA
      • 20.3.9.1. Overview
      • 20.3.9.2. Treatment Type Portfolio
      • 20.3.9.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.9.4. Sales Footprint
      • 20.3.9.5. Strategy Overview
    • 20.3.10. NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
      • 20.3.10.1. Overview
      • 20.3.10.2. Treatment Type Portfolio
      • 20.3.10.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.10.4. Sales Footprint
      • 20.3.10.5. Strategy Overview
    • 20.3.11. Bio-Oil (Union Swiss (Pty) Ltd)
      • 20.3.11.1. Overview
      • 20.3.11.2. Treatment Type Portfolio
      • 20.3.11.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.11.4. Sales Footprint
      • 20.3.11.5. Strategy Overview
    • 20.3.12. Merz Pharma
      • 20.3.12.1. Overview
      • 20.3.12.2. Treatment Type Portfolio
      • 20.3.12.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.12.4. Sales Footprint
      • 20.3.12.5. Strategy Overview
    • 20.3.13. Dermaclara
      • 20.3.13.1. Overview
      • 20.3.13.2. Treatment Type Portfolio
      • 20.3.13.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.13.4. Sales Footprint
      • 20.3.13.5. Strategy Overview
    • 20.3.14. Unilever
      • 20.3.14.1. Overview
      • 20.3.14.2. Treatment Type Portfolio
      • 20.3.14.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.14.4. Sales Footprint
      • 20.3.14.5. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology